Bio Insight Bio Feature
In this interview, we have the pleasure of speaking with Nataliya Andreychuk, the CEO of Viseven, about her experience and insights on Women's leadership i...
February 27, 2023 | Influencers
Australia and New Zealand have always been at the forefront of innovation and research in the biopharma industry. The region's strategic location and stron...
February 24, 2023 | News
By studying and replicating natural systems, scientists are uncovering new avenues for drug development, medical device design, and even disease prevention...
February 17, 2023 | Opinion
Can you explain the details of the new medicine now available on the Pharmaceutical Benefits Scheme for people with Parkinson's disease? Ongentys (opicapo...
February 13, 2023 | News
How is GenScript planning to meet the growing demand for cell and gene therapies in 2023? GenScript is committed to advancing non-viral gene and cell ther...
February 01, 2023 | Influencers
How is success in the discovery of small molecule ligands increased with the Optimer platform? The Optimer platform incorporates three se...
January 04, 2023 | News
The Award ceremony of the Sheikh Hamdan bin Rashid Al Maktoum Award for Medical Sciences, hosted in Dubai, took place on 23rd of ...
November 25, 2022 | News
We tend to put off investments in improvements and instead opt to play it safe, taking a conservative approach to weathering the economic storm. For ...
November 01, 2022 | News | By Michelle Tanner, CFO, MasterControl
Q1. What emerging trends are shaping the future of research in Virology? This is an extraordinary time in which infectious disease research ...
October 25, 2022 | Influencers
Dr. Shneider is the CEO of CureLab Oncology, bringing more than 25 years of biotech and entrepreneurial experience. He is currently a senior resear...
October 17, 2022 | News
There are now 1,300 companies actively involved in cell and gene therapy manufacturing1 and 11 gene therapy medicinal products with valid marketi...
October 07, 2022 | Opinion | By By James Jardine, GxP Lifeline Editor, MasterControl
A growing bulk of this demand comes from biologics which have become the mainstay of treatment methods from cancer to autoimmune disorder to viral infectio...
August 15, 2022 | Opinion | By Francis Van Parys, Vice President (Commercial) APAC at Cytiva
The State of COVID-19 in Asia Pacific Across Asia, over 130 million[1] COVID-19 cases have been reported across 39 countries from the time the first case ...
July 13, 2022 | Opinion | By Dr Paul Shea Tat Ming, Specialist in Geriatrics
What are the major plans in store for G42 Healthcare? Any new segments to be explored? G42 Healthcare is transforming the traditional he...
June 28, 2022 | News
Most Read
Bio Jobs
News
Editor Picks